Literature DB >> 19880521

Identification of a functional network of human epigenetic silencing factors.

Andrey Poleshko1, Margret B Einarson, Natalia Shalginskikh, Rugang Zhang, Peter D Adams, Anna Marie Skalka, Richard A Katz.   

Abstract

Epigenetic silencing is mediated by families of factors that place, remove, read, and transmit repressive histone and DNA methylation marks on chromatin. How the roles for these functionally diverse factors are specified and integrated is the subject of intense study. To address these questions, HeLa cells harboring epigenetically silent green fluorescent protein reporter genes were interrogated with a small interference RNA library targeting 200 predicted epigenetic regulators, including potential activators, silencers, chromatin remodelers, and ancillary factors. Using this approach, individual, or combinatorial requirements for specific epigenetic silencing factors could be detected by measuring green fluorescent protein reactivation after small interference RNA-based factor knockdown. In our analyses, we identified a specific subset of 15 epigenetic factors that are candidates for participation in a functional epigenetic silencing network in human cells. These factors include histone deacetylase 1, de novo DNA methyltransferase 3A, components of the polycomb PRC1 complex (RING1 and HPH2), and the histone lysine methyltransferases KMT1E and KMT5C. Roles were also detected for two TRIM protein family members, the cohesin component Rad21, and the histone chaperone CHAF1A (CAF-1 p150). Remarkably, combinatorial knockdown of factors was not required for reactivation, indicating little functional redundancy. Consistent with this interpretation, knockdown of either KMT1E or CHAF1A resulted in a loss of multiple histone-repressive marks and concomitant gain of activation marks on the promoter during reactivation. These results reveal how functionally diverse factors may cooperate to maintain gene silencing during normal development or in disease. Furthermore, the findings suggest an avenue for discovery of new targets for epigenetic therapies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880521      PMCID: PMC2804189          DOI: 10.1074/jbc.M109.064667

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

2.  Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly.

Authors:  Shireen A Sarraf; Irina Stancheva
Journal:  Mol Cell       Date:  2004-08-27       Impact factor: 17.970

3.  High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms.

Authors:  Richard A Katz; Emily Jack-Scott; Anna Narezkina; Ivan Palagin; Pamela Boimel; Joseph Kulkosky; Emmanuelle Nicolas; James G Greger; Anna Marie Skalka
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

Review 4.  Multivalent engagement of chromatin modifications by linked binding modules.

Authors:  Alexander J Ruthenburg; Haitao Li; Dinshaw J Patel; C David Allis
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

5.  New nomenclature for chromatin-modifying enzymes.

Authors:  C David Allis; Shelley L Berger; Jacques Cote; Sharon Dent; Thomas Jenuwien; Tony Kouzarides; Lorraine Pillus; Danny Reinberg; Yang Shi; Ramin Shiekhattar; Ali Shilatifard; Jerry Workman; Yi Zhang
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

Review 6.  Phenotypic plasticity and the epigenetics of human disease.

Authors:  Andrew P Feinberg
Journal:  Nature       Date:  2007-05-24       Impact factor: 49.962

Review 7.  Epigenetic therapy of cancer: past, present and future.

Authors:  Christine B Yoo; Peter A Jones
Journal:  Nat Rev Drug Discov       Date:  2006-01       Impact factor: 84.694

Review 8.  Linking DNA methylation and histone modification: patterns and paradigms.

Authors:  Howard Cedar; Yehudit Bergman
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

Review 9.  Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug.

Authors:  Paul A Marks; Ronald Breslow
Journal:  Nat Biotechnol       Date:  2007-01       Impact factor: 54.908

Review 10.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

View more
  35 in total

1.  Uncovering the human methyltransferasome.

Authors:  Tanya C Petrossian; Steven G Clarke
Journal:  Mol Cell Proteomics       Date:  2010-10-07       Impact factor: 5.911

2.  The human protein PRR14 tethers heterochromatin to the nuclear lamina during interphase and mitotic exit.

Authors:  Andrey Poleshko; Katelyn M Mansfield; Caroline C Burlingame; Mark D Andrake; Neil R Shah; Richard A Katz
Journal:  Cell Rep       Date:  2013-10-31       Impact factor: 9.423

3.  Selective Recognition of H3.1K36 Dimethylation/H4K16 Acetylation Facilitates the Regulation of All-trans-retinoic Acid (ATRA)-responsive Genes by Putative Chromatin Reader ZMYND8.

Authors:  Santanu Adhikary; Sulagna Sanyal; Moitri Basu; Isha Sengupta; Sabyasachi Sen; Dushyant Kumar Srivastava; Siddhartha Roy; Chandrima Das
Journal:  J Biol Chem       Date:  2015-12-11       Impact factor: 5.157

4.  Analysis of the human endogenous coregulator complexome.

Authors:  Anna Malovannaya; Rainer B Lanz; Sung Yun Jung; Yaroslava Bulynko; Nguyen T Le; Doug W Chan; Chen Ding; Yi Shi; Nur Yucer; Giedre Krenciute; Beom-Jun Kim; Chunshu Li; Rui Chen; Wei Li; Yi Wang; Bert W O'Malley; Jun Qin
Journal:  Cell       Date:  2011-05-27       Impact factor: 41.582

5.  Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression.

Authors:  P Joel Ross; Michael A Kennedy; Carin Christou; Milagros Risco Quiroz; Kathy L Poulin; Robin J Parks
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

Review 6.  Higher-order orchestration of hematopoiesis: is cohesin a new player?

Authors:  Anil K Panigrahi; Debananda Pati
Journal:  Exp Hematol       Date:  2012-09-26       Impact factor: 3.084

7.  A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis.

Authors:  Andrew Volk; Kaiwei Liang; Praveen Suraneni; Xinyu Li; Jianyun Zhao; Marinka Bulic; Stacy Marshall; Kirthi Pulakanti; Sebastien Malinge; Jeffrey Taub; Yubin Ge; Sridhar Rao; Elizabeth Bartom; Ali Shilatifard; John D Crispino
Journal:  Cancer Cell       Date:  2018-11-12       Impact factor: 31.743

8.  Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia.

Authors:  Ki-Youb Park; Joshua R Fletcher; Ann C Raddant; Andrew F Russo
Journal:  Cephalalgia       Date:  2011-01-07       Impact factor: 6.292

9.  Degeneracy allows for both apparent homogeneity and diversification in populations.

Authors:  James M Whitacre; Sergei P Atamas
Journal:  Biosystems       Date:  2012-08-10       Impact factor: 1.973

10.  Systematic identification of factors for provirus silencing in embryonic stem cells.

Authors:  Bin Xia Yang; Chadi A El Farran; Hong Chao Guo; Tao Yu; Hai Tong Fang; Hao Fei Wang; Sharon Schlesinger; Yu Fen Samantha Seah; Germaine Yen Lin Goh; Suat Peng Neo; Yinghui Li; Matthew C Lorincz; Vinay Tergaonkar; Tit-Meng Lim; Lingyi Chen; Jayantha Gunaratne; James J Collins; Stephen P Goff; George Q Daley; Hu Li; Frederic A Bard; Yuin-Han Loh
Journal:  Cell       Date:  2015-09-10       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.